Relates to the availability of opioid reversal agents

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 16 Sponsors

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

Chamber: House
Introduced: Jan 8, 2025
Last action: Jan 12, 2026 — REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
Session: 2025-2026
Momentum: 76 · High

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Passed First Chamber — base rate 16%, measured from NY's completed sessions
Momentum +6 76/100 from the pace of recorded action
Time since last action -22 281 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.